Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1986 Aug;124(2):286–293.

Inhibition of experimental autoimmune tubulointerstitial nephritis in Brown-Norway rats by (15S)-15-methyl prostaglandin E1. Analysis of the effect of prostaglandin E1 on the induction of the humoral immune response and the elicitation of humorally mediated inflammation.

T R Ulich, R X Ni
PMCID: PMC1888301  PMID: 3740216

Abstract

Brown-Norway (BN) rats develop tubulointerstitial nephritis (TIN) after immunization with bovine tubular basement membrane (TBM) and adjuvants. Daily subcutaneous injections (either on Days 0-7 or Days 0-14) of (15S)-15-methyl prostaglandin E1 (M-PGE1) at a dose of 1 mg/kg/day markedly inhibited or completely abrogated the development of both the acute polymorphonuclear (Day 10) and the subsequent mononuclear (Day 14) inflammatory phases of BN rat TIN. Circulating anti-TBM antibody in Days 0-7 M-PGE1-treated rats was moderately diminished on Day 8 after immunization but not on Day 14. Circulating anti-TBM antibody in Days 0-14 M-PGE1-treated rats was only slightly diminished on Day 14. In experiments to test the effect of M-PGE1 on the elicitation phase of humorally mediated inflammation, M-PGE1 inhibited the acute inflammatory response observed 6 hours after intradermal injection of particulate TBM into TBM-sensitized BN rats. The inflammation in these skin tests was demonstrated by passive transfer experiments to be humorally mediated. The inhibition of acute humorally mediated intradermal inflammation was not attributable to neutropenia, because M-PGE1 caused a significant neutrophilia as demonstrated by peripheral blood smears. Although the inhibition of TIN in Days 0-14 M-PGE1-treated rats may have been due, in part, to dysfunction of the elicitation phase of humorally mediated inflammation, the inhibition of TIN in Days 0-7 M-PGE1-treated rats was more likely secondary to the diminished induction of either humoral or cellular immunity.

Full text

PDF
286

Images in this article

290Figure 5
on p.290
291Figure 6
on p.291
292Figure 7
on p.292

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chensue S. W., Kunkel S. L., Ward P. A., Higashi G. I. Exogenously administered prostaglandins modulate pulmonary granulomas induced by Schistosoma mansoni eggs. Am J Pathol. 1983 Apr;111(1):78–87. [PMC free article] [PubMed] [Google Scholar]
  2. Darte C., Beaufay H. Subcellular localization of the PGE2 synthesis activity in mouse resident peritoneal macrophages. J Exp Med. 1984 Jan 1;159(1):89–102. doi: 10.1084/jem.159.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fantone J. C., Kunkel R. G., Kinnes D. A. Potentiation of alpha-naphthyl thiourea-induced lung injury by prostaglandin E1 and platelet depletion. Lab Invest. 1984 Jun;50(6):703–710. [PubMed] [Google Scholar]
  4. Fantone J. C., Kunkel S. L., Ward P. A. Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1. Prostaglandins Med. 1981 Aug;7(2):195–198. doi: 10.1016/0161-4630(81)90062-8. [DOI] [PubMed] [Google Scholar]
  5. Ferwerda W., Meijer J. F., van den Eijnden D. H., van Dijk W. Epithelial basement membrane of bovine renal tubuli. Isolation and chemical characterization. Hoppe Seylers Z Physiol Chem. 1974 Aug;355(8):976–984. doi: 10.1515/bchm2.1974.355.2.976. [DOI] [PubMed] [Google Scholar]
  6. Garin E. H., Richard G. A. Prostaglandin synthesis inhibitors and primary antibody response in experimental nephrotic syndrome. Clin Immunol Immunopathol. 1984 Jan;30(1):129–133. doi: 10.1016/0090-1229(84)90013-8. [DOI] [PubMed] [Google Scholar]
  7. Goodwin J. S., Webb D. R. Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol. 1980 Jan;15(1):106–122. doi: 10.1016/0090-1229(80)90024-0. [DOI] [PubMed] [Google Scholar]
  8. Grunnet I., Bojesen E. Prostaglandin E1 high affinity binding sites of rat thymocytes. Specificity and blockade by non-steroidal antiinflammatory drugs and localization in a plasma membrane-enriched fraction. Biochim Biophys Acta. 1976 Jan 21;419(2):365–378. doi: 10.1016/0005-2736(76)90363-1. [DOI] [PubMed] [Google Scholar]
  9. Kelley V. E., Winkelstein A., Izui S., Dixon F. J. Prostaglandin E1 inhibits T-cell proliferation and renal disease in MRL/1 mice. Clin Immunol Immunopathol. 1981 Nov;21(2):190–203. doi: 10.1016/0090-1229(81)90208-7. [DOI] [PubMed] [Google Scholar]
  10. Kunkel S. L., Thrall R. S., Kunkel R. G., McCormick J. R., Ward P. A., Zurier R. B. Suppression of immune complex vasculitis in rats by prostaglandin. J Clin Invest. 1979 Nov;64(5):1525–1529. doi: 10.1172/JCI109611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kunkel S. L., Zanetti M., Sapin C. Suppression of nephrotoxic serum nephritis in rats by prostaglandin E1. Am J Pathol. 1982 Aug;108(2):240–245. [PMC free article] [PubMed] [Google Scholar]
  12. Lehman D. H., Wilson C. B., Dixon F. J. Interstitial nephritis in rats immunized with heterologous tubular basement membrane. Kidney Int. 1974 Mar;5(3):187–195. doi: 10.1038/ki.1974.23. [DOI] [PubMed] [Google Scholar]
  13. Lehman D. H., Wilson C. B. Role of sensitized cells in antitubular basement membrane interstitial nephritis. Int Arch Allergy Appl Immunol. 1976;51(2):168–174. doi: 10.1159/000231589. [DOI] [PubMed] [Google Scholar]
  14. Leslie C. A., Levine L. Evidence for the presence of a prostaglandin E 2 -9-keto reductase in rat organs. Biochem Biophys Res Commun. 1973 Jun 8;52(3):717–724. doi: 10.1016/0006-291x(73)90996-0. [DOI] [PubMed] [Google Scholar]
  15. Mampaso F. M., Wilson C. B. Characterization of inflammatory cells in autoimmune tubulointerstitial nephritis in rats. Kidney Int. 1983 Mar;23(3):448–457. doi: 10.1038/ki.1983.41. [DOI] [PubMed] [Google Scholar]
  16. Neilson E. G., Gasser D. L., McCafferty E., Zakheim B., Phillips S. M. Polymorphism of genes involved in anti-tubular basement membrane disease in rats. Immunogenetics. 1983;17(1):55–65. doi: 10.1007/BF00364289. [DOI] [PubMed] [Google Scholar]
  17. Parker C. W., Stenson W. F., Huber M. G., Kelly J. P. Formation of thromboxane B2 and hydroxyarachidonic acids in purified human lymphocytes in the presence and absence of PHA. J Immunol. 1979 Apr;122(4):1572–1577. [PubMed] [Google Scholar]
  18. Rivkin I., Rosenblatt J., Becker E. L. The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. J Immunol. 1975 Oct;115(4):1126–1134. [PubMed] [Google Scholar]
  19. Stenson W. F., Parker C. W. Prostaglandins, macrophages, and immunity. J Immunol. 1980 Jul;125(1):1–5. [PubMed] [Google Scholar]
  20. Stone K. J., Hart M. Inhibition of renal PGE2-9-ketoreductase by diuretics. Prostaglandins. 1976 Aug;12(2):197–207. doi: 10.1016/0090-6980(76)90115-5. [DOI] [PubMed] [Google Scholar]
  21. Sugisaki T., Klassen J., Milgrom F., Andres G. A., McCluskey R. T. Immunopathologic study of an autoimmune tubular and interstitial renal disease in brown Norway rats. Lab Invest. 1973 Jun;28(6):658–671. [PubMed] [Google Scholar]
  22. Till G., Kownatzki E., Seitz M., Gemsa D. Chemokinetic and chemotactic activity of various prostaglandins for neutrophil granulocytes. Clin Immunol Immunopathol. 1979 Jan;12(1):111–118. doi: 10.1016/0090-1229(79)90116-8. [DOI] [PubMed] [Google Scholar]
  23. Ulich T. R., Bannister K. M., Wilson C. B. Tubulointerstitial nephritis induced in the brown Norway rat with chaotropically solubilized bovine tubular basement membrane: the model and the humoral and cellular responses. Clin Immunol Immunopathol. 1985 Aug;36(2):187–200. doi: 10.1016/0090-1229(85)90120-5. [DOI] [PubMed] [Google Scholar]
  24. Ulich T. R., Dakay E. B., Williams J. H., Ni R. X., Cairo M. S. (15S)-15-methyl prostaglandin E1-induced neutrophilia in Brown-Norway rats. Prostaglandins Leukot Med. 1985 Nov;20(2):169–173. doi: 10.1016/0262-1746(85)90007-1. [DOI] [PubMed] [Google Scholar]
  25. Webb D. R., Osheroff P. L. Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1300–1304. doi: 10.1073/pnas.73.4.1300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Winkelstein A., Kelley V. E. The pharmacologic effects of PGE1 on murine lymphocytes. Blood. 1980 Mar;55(3):437–443. [PubMed] [Google Scholar]
  27. Woodroffe A. J., Wilson C. B. An evaluation of elution techniques in the study of immune complex glomerulonephritis. J Immunol. 1977 May;118(5):1788–1794. [PubMed] [Google Scholar]
  28. Zimecki M., Webb D. R. The regulation of the immune response to T-independent antigens by prostaglandins and B cells. J Immunol. 1976 Dec;117(6):2158–2164. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES